Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Lysosome	6/128	2.806581391919395e-09	2.5259232527274558e-08	97.69672131147541	-290.9287426236646	ARSB;FUCA1;GAA;GBA;IDS;IDUA
KEGG_2021_Human	Glycosaminoglycan degradation	3/19	1.3103428309570358e-06	5.896542739306661e-06	215.67857142857142	-263.33895641664805	ARSB;IDS;IDUA
KEGG_2021_Human	Other glycan degradation	2/18	0.00020882825738589695	0.0006264847721576909	125.8125	-112.45913199218819	FUCA1;GBA
KEGG_2021_Human	Galactose metabolism	1/31	0.03774052193970927	0.07867107818693414	29.77037037037037	-16.126223630092912	GAA
KEGG_2021_Human	Starch and sucrose metabolism	1/36	0.043706154548296745	0.07867107818693414	25.501587301587303	-14.206754592243437	GAA
KEGG_2021_Human	Sphingolipid metabolism	1/49	0.05906133610748362	0.08859200416122544	18.564814814814813	-10.829316375605623	GBA
KEGG_2021_Human	Parkinson disease	1/249	0.2689494049142217	0.3457920920325708	3.503584229390681	-1.6629804039719844	SNCA
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.42034166328432465	2.32487922705314	-0.8103995559567543	SNCA
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	SNCA
